These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30104277)

  • 1. Activity of Aromathecins against African Trypanosomes.
    Nenortas NP; Cinelli MA; Morrell AE; Cushman M; Shapiro TA
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
    Tang SC; Shapiro TA
    Antimicrob Agents Chemother; 2010 Feb; 54(2):620-6. PubMed ID: 20008775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-trypanosomal activities of DNA topoisomerase inhibitors.
    Deterding A; Dungey FA; Thompson KA; Steverding D
    Acta Trop; 2005 Mar; 93(3):311-6. PubMed ID: 15715983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
    Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
    Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems.
    Hannaert V
    Planta Med; 2011 Apr; 77(6):586-97. PubMed ID: 20945274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
    Jones AJ; Kaiser M; Avery VM
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
    Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
    Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.
    Lüscher A; de Koning HP; Mäser P
    Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New heterocyclic compounds: Synthesis and antitrypanosomal properties.
    Pomel S; Dubar F; Forge D; Loiseau PM; Biot C
    Bioorg Med Chem; 2015 Aug; 23(16):5168-74. PubMed ID: 25835356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent antitrypanosomal activities of heat shock protein 90 inhibitors in vitro and in vivo.
    Meyer KJ; Shapiro TA
    J Infect Dis; 2013 Aug; 208(3):489-99. PubMed ID: 23630365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of indenoisoquinolines against African trypanosomes.
    Bakshi RP; Sang D; Morrell A; Cushman M; Shapiro TA
    Antimicrob Agents Chemother; 2009 Jan; 53(1):123-8. PubMed ID: 18824603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma brucei.
    Caffrey CR; Schanz M; Nkemngu NJ; Brush M; Hansell E; Cohen FE; Flaherty TM; McKerrow JH; Steverding D
    Int J Antimicrob Agents; 2002 Mar; 19(3):227-31. PubMed ID: 11932146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic and curative action of Ridzol-S and Ronidazole in experimental trypanosomiasis caused by Trypanosoma brucei et T. evansi].
    Tchalim TK
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):263-70. PubMed ID: 7195691
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel distamycin analogues that block the cell cycle of African trypanosomes with high selectivity and potency.
    Franco J; Scarone L; Comini MA
    Eur J Med Chem; 2020 Mar; 189():112043. PubMed ID: 31978782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diamidine activity against trypanosomes: the state of the art.
    Soeiro MN; de Castro SL; de Souza EM; Batista DG; Silva CF; Boykin DW
    Curr Mol Pharmacol; 2008 Jun; 1(2):151-61. PubMed ID: 20021429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemistry of African trypanosomes and its significance for chemotherapy.
    Braide VB
    J Vet Pharmacol Ther; 1987 Sep; 10(3):191-201. PubMed ID: 3309362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.